Saturday 17 October 2026
Export SYBX’s income statement to Excel — free account
Synlogic, Inc.
SYBX Healthcare Biotechnology
Synlogic, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $8,000.00, down 99.8% from fiscal 2023. In the quarter to June 2026, EPS was flat and free cash flow fell 277.9%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.
1.00
0.08
−7.41%
Follow SYBX
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | 4 | 3 | 1 | 4 | 2 | 3 | 3 | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Altman Z-Score |
(3.08) | 1.30 | 4.80 | 0.06 | (1.18) | 0.30 | (4.61) | (9.45) | (35.79) | — |
P/S ratio |
0.00 | 29.74 | 66.47 | 35.15 | 43.61 | 76.38 | 45.10 | 8.62 | 5.33 | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Altman Z″-Score (non-manufacturers) |
(6.06) | 6.23 | 8.21 | 4.63 | 0.66 | 2.49 | (7.51) | (20.45) | (80.41) | — |
P/Operating CF |
(3.02) | (8.06) | (18.69) | (6.97) | (7.83) | (10.26) | (4.29) | (5.26) | (30.06) | — |
P/B ratio |
0.00 | 0.85 | 1.35 | 0.50 | 0.67 | 0.91 | 0.64 | 0.89 | 1.34 | — |
Price to Tangible BV |
0.00 | 0.85 | 1.35 | 0.50 | 0.67 | 0.91 | 0.64 | 0.89 | 1.34 | — |
EV/Sales |
0.00 | (5.68) | 17.85 | (18.61) | (1.53) | 3.08 | (20.68) | (5.54) | (0.56) | — |
EV/EBITDA |
0.00 | 0.36 | 0.00 | 0.78 | 0.05 | 0.00 | 0.37 | 0.35 | 0.04 | — |
EV/Operating CF |
(0.27) | 0.45 | (1.06) | 0.55 | 0.07 | (0.10) | 0.43 | 0.36 | 0.06 | — |
EV/FCF |
(0.25) | 0.41 | (0.93) | 0.54 | 0.07 | (0.10) | 0.42 | 0.36 | 0.06 | — |
Quick Ratio |
3.48 | 9.64 | 14.71 | 13.49 | 12.10 | 12.76 | 6.40 | 1.58 | 2.67 | 4.09 |
Current Ratio |
3.84 | 9.81 | 14.91 | 15.03 | 12.87 | 13.23 | 6.58 | 1.65 | 2.80 | 4.30 |
Net Debt/EBITDA |
0.71 | 2.25 | 2.44 | 2.26 | 1.39 | 2.21 | 1.18 | 0.88 | 0.46 | 3.66 |
Debt/Assets |
0.88% | 0.47% | 0.15% | 0.00% | 14.09% | 0.01% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.01 | 0.01 | 0.00 | 0.00 | 0.18 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.01 | 0.04 | 0.02 | 0.01 | 0.00 | 0.01 | 0.01 | 0.04 | 0.00 | 0.00 |
Operating CF/Net income |
0.97 | 0.77 | 0.88 | 1.47 | 0.67 | 0.86 | 0.86 | 0.84 | 1.36 | 4.34 |
Capex/Depreciation |
(2.65) | (1.11) | (5.54) | (0.88) | (0.15) | (0.25) | (0.42) | (0.17) | 12.54 | 0.00 |
Interest Coverage |
(2,994.86) | (716.21) | (1,191.40) | (2,590.90) | (10,077.67) | (30,382.50) | (33,709.50) | (55,161.00) | — | — |
| (77.09%) | (148.49%) | (46.32%) | (36.56%) | (43.50%) | (46.16%) | (57.55%) | (106.21%) | (102.63%) | (8.17%) | |
| (37.77%) | (67.44%) | (40.36%) | (31.24%) | (35.60%) | (38.02%) | (46.32%) | (65.74%) | (48.98%) | (5.70%) | |
ROIC |
0.00% | 0.00% | (2,027.79%) | (91.08%) | (108.09%) | (203.14%) | (845.27%) | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(136.23%) | (45.19%) | (37.02%) | (37.39%) | (54.13%) | (45.77%) | (88.22%) | (242.93%) | (183.91%) | (8.51%) |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Research and Development Expense of Revenue |
3,380.63% | 1,241.45% | 1,509.29% | 1,884.22% | 8,710.83% | 2,686.83% | 4,410.51% | 1,304.39% | 114,425.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
1,440.99% | 528.93% | 623.65% | 662.23% | 2,483.85% | 877.54% | 1,402.97% | 431.95% | 82,887.50% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
83.11% | 108.51% | 171.31% | 185.88% | 716.88% | 191.62% | 308.39% | 83.24% | 39,612.50% | 0.00% |
Graham Net Nets |
0.48 | 1.02 | 0.65 | 1.30 | 1.01 | 0.79 | 0.97 | 0.25 | 0.74 | — |
Graham Number |
1,011.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Earnings Yield |
(82.47%) | (107.30%) | (29.09%) | (66.63%) | (76.35%) | (47.08%) | (125.27%) | (243.33%) | (172.70%) | — |
Free Cash Flow Yield |
(111.97%) | (46.26%) | (28.73%) | (98.14%) | (51.58%) | (39.47%) | (108.25%) | (178.27%) | (177.70%) | — |
Revenue per Share |
4.22 | 5.45 | 1.58 | 1.10 | 0.23 | 0.48 | 0.25 | 0.52 | 0.00 | 0.00 |
Operating CF per Share |
(194.18) | (69.23) | (26.66) | (37.36) | (16.55) | (14.14) | (11.90) | (7.94) | (2.60) | (0.35) |
Capex per Share |
(17.44) | (5.72) | (3.55) | (0.62) | (0.17) | (0.18) | (0.15) | (0.03) | 0.11 | 0.01 |
Free Cash Flow per Share |
(211.62) | (74.95) | (30.21) | (37.98) | (16.71) | (14.33) | (12.05) | (7.97) | (2.49) | (0.34) |
Cash per Share |
138.78 | 193.99 | 77.04 | 59.20 | 42.02 | 34.84 | 16.23 | 7.34 | 1.55 | 1.19 |
Shareholders Equity per Share |
128.48 | 189.56 | 77.90 | 77.68 | 48.17 | 39.90 | 17.28 | 5.04 | 1.05 | 0.96 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
128.48 | 189.56 | 77.90 | 77.68 | 48.17 | 39.90 | 17.28 | 5.04 | 1.05 | 0.96 |
Free Cash Flow |
(22.24) | (33.62) | (48.12) | (76.72) | (39.95) | (52.88) | (57.62) | (51.81) | (30.34) | (4.19) |
Working Capital |
11.88 | 79.56 | 116.00 | 124.38 | 98.55 | 123.23 | 67.66 | 19.62 | 12.70 | 11.81 |
Capital Expenditures |
(1.83) | (2.57) | (5.65) | (1.25) | (0.39) | (0.68) | (0.73) | (0.20) | 1.32 | 0.17 |
Net Current Asset Value |
9.53 | 73.93 | 108.10 | 101.58 | 78.14 | 105.84 | 51.53 | 7.13 | 12.70 | 11.81 |
EV/EBIT |
0.00 | 0.34 | 0.00 | 0.76 | 0.05 | 0.00 | 0.36 | 0.34 | 0.04 | — |
Capex to Sales |
4.13 | 1.05 | 2.24 | 0.56 | 0.72 | 0.39 | 0.62 | 0.06 | (164.62) | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.20 | 0.24 | 0.07 | 0.11 | 0.24 | 0.30 | 0.24 | 0.20 | 0.00 | — |
Cash ROIC |
(78.68%) | (19.49%) | (19.48%) | (27.75%) | (16.94%) | (19.17%) | (35.96%) | (64.35%) | (95.98%) | (15.80%) |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | — | — | — | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | — | — | — | 0.00 | — | — | — |
Average Payables |
2.34 | 1.83 | 2.55 | 2.29 | 2.08 | 1.97 | 1.86 | 1.62 | 0.81 | 0.13 |
Average Assets |
55.48 | 59.87 | 120.02 | 164.46 | 166.21 | 159.29 | 142.80 | 93.21 | 47.69 | 17.64 |
Average Common Equity |
27.18 | 27.19 | 104.57 | 140.50 | 136.02 | 131.20 | 114.94 | 57.69 | 22.76 | 12.31 |
Columns are period end dates